Minotrol 16, Model Numbers: 2043748, 2043752, 2043756, Lot Number: MX090(Levels: Low, Normal, and...

FDA Device Recall #Z-0429-2013 — Class III — September 14, 2012

Recall Summary

Recall Number Z-0429-2013
Classification Class III — Low risk
Date Initiated September 14, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Horiba Instruments, Inc dba Horiba Medical
Location Irvine, CA
Product Type Devices
Quantity 22,954

Product Description

Minotrol 16, Model Numbers: 2043748, 2043752, 2043756, Lot Number: MX090(Levels: Low, Normal, and High). Minotrol 16 is a tri-level control intended for in vitro diagnostic use in monitoring the accuracy and precision on HORIBA Medical hematology blood cell counters using HORIBA Medical reagents. Minotrol 16 is an in vitro diagnostic reagent composed of human erythrocytes, mammalian leukocytes, and platelets in a plasma-like fluid with preservatives. Minotrol 16 is a stable material that provides a means of determining the accuracy and precision of hematology blood cell counters. It is handled in the same manner as a patient specimen. The assay tables are determined on validated instruments using the appropriate reagents

Reason for Recall

HORIBA Medical Irvine Technical Support received reports from some customers that have experienced high recover values for Hemoglobin when using Minotrol 16 lot #MX090 (Level High). Customer communication was sent 10/01/2010.

Distribution Pattern

Nationwide Distribution

Lot / Code Information

Model Numbers: 2043748, 2043752, 2043756, Lot Number: MX090(Levels Low, Normal, and High).

Other Recalls from Horiba Instruments, Inc dba Horiba Me...

Recall # Classification Product Date
Z-2286-2018 Class II ABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, RE... Apr 26, 2018
Z-0494-2018 Class II 15 ML REAGENT CUP, B1037307, SAP 1221037307 for... Nov 21, 2017
Z-0493-2018 Class II 10 ML REAGENT CUP, B1034626, SAP 1221034626 for... Nov 21, 2017
Z-0902-2015 Class II ABX PENTRA Reagent Container, Model No. B103730... Nov 13, 2014
Z-2692-2014 Class II ABX PENTRA Magnesium RTU Reagent, Part No. A11A... Aug 11, 2014

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.